返回 Agenda
Session 1: IMI PREFER - Journey and Motivations
Session Chair(s)
Isabelle Huys, PHARMD, PHD, MPHARM
Professor
KU Leuven, Belgium
Jürgen Kübler, PHD
Owner
Quantitative Scientific Consulting, Germany
Session 1: IMI PREFER - Journey and Motivations
Speaker(s)
What are Patient Preferences? Previous work on Landscape Setting and Projects’ collection: what is happening right now? The Value of PPS
Axel Mühlbacher
University of Applied Sciences Neubrandenburg, Germany
Professorship in Health Economics and Medical Management
What are Patient Preferences? Previous work on Landscape Setting and Projects’ collection: what is happening right now? The Value of PPS
Kevin Marsh, PHD, MSC
Evidera, United Kingdom
Vice President, Patient-Centered Research
Why is there a need for a Project like PREFER?
Rebecca Noel, DrPH, MPH
Eli Lilly, United States
Executive Director, Benefit-Risk Assessment
How is PREFER bridging the gap?
Sheila Dickinson, MSC
Novartis Pharma AG, Switzerland
Global Benefit-Risk Lead